• About us
    • Overview
    • Our People
    • Events
    • Our Facilities
    • News
    • Sustainability
    • Integrity and Ethics
  • Our Services
    • Overview
    • Analytics
    • Process Development
    • Quality and Regulatory
    • Manufacturing
  • Viral Vectors
    • LentiVector® platform
    • inAAVate™ platform
    • Other Viral Vectors
  • Knowledge Centre
  • Careers
  • Investors
    • Analyst coverage
    • Registrars
    • Investor contacts
    • Share Price Information
    • Results, Reports, Presentations & Webcasts
    • Regulatory News
    • Shareholder Meetings, Circulars & Prospectuses
    • Acquisition of ABL Europe (Oxford Biomedica France SAS)
    • Corporate Governance
    • Board Committees
    • Subsidiaries governance & compliance
    • Warning to Shareholders
    • Investor Calendar
  • Get In Touch
OXB
  • About us
    • Overview
    • Our People
    • Events
    • Our Facilities
    • News
    • Sustainability
    • Integrity and Ethics
  • Our Services
    • Overview
    • Analytics
    • Process Development
    • Quality and Regulatory
    • Manufacturing
  • Viral Vectors
    • LentiVector® platform
    • inAAVate™ platform
    • Other Viral Vectors
  • Knowledge Centre
  • Careers
  • Investors
    • Analyst coverage
    • Registrars
    • Investor contacts
    • Share Price Information
    • Results, Reports, Presentations & Webcasts
    • Regulatory News
    • Shareholder Meetings, Circulars & Prospectuses
    • Acquisition of ABL Europe (Oxford Biomedica France SAS)
    • Corporate Governance
    • Board Committees
    • Subsidiaries governance & compliance
    • Warning to Shareholders
    • Investor Calendar
  • Get In Touch

EHD 17th January 2017 v4

17 January 2018

Continue reading

Test

OXB
  • Privacy policy
  • Cookies policy
  • Modern slavery
  • Legal notice
  • Media Assets

Oxford Biomedica PLC, Windrush Court, Transport Way, Oxford, OX4 6LT, United Kingdom

© 2024 Oxford Biomedica PLC | Company No. 03252665 | VAT No. GB 663 6533 21